News

Zydus Lifesciences inks licensing, commercialisation pact with RK Pharma

Zydus Lifesciences has partnered with RK Pharma Inc of the US. They will collaborate on a new sterile injectable oncology supportive care product for the US market. RK Pharma will handle manufacturing and supply. Zydus will manage the new drug application submission and commercialisation. The product is expected to be filed in 2026.